Stratec SE Share Price
Stocks
SBS
DE000STRA555
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.55 EUR | -0.48% |
|
+1.48% | -8.46% |
| 15/07 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reaffirms its Neutral rating | ZD |
| 03/07 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg gives a Buy rating | ZD |
| Market Cap | 25Cr 29Cr 23Cr 21Cr 40Cr 2.76TCr 41Cr 275.54Cr 107.96Cr 1.38TCr 108.76Cr 106.39Cr 4.61TCr | P/E 2026 * |
20.1x | P/E 2027 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise Value | 35Cr 41Cr 33Cr 30Cr 57Cr 3.87TCr 57Cr 385.97Cr 151.22Cr 1.94TCr 152.34Cr 149.02Cr 6.46TCr | EV / Sales 2026 * |
1.32x | EV / Sales 2027 * | 1.23x |
| Free-Float |
39.08% | Yield 2026 * |
3.25% | Yield 2027 * | 3.74% |
Last Transcript: Stratec SE
| 1 day | -0.97% | ||
| 1 week | +1.48% | ||
| Current month | +5.28% | ||
| 1 month | +7.03% | ||
| 3 months | +19.62% | ||
| 6 months | +4.85% | ||
| Current year | -8.46% |
| 1 week | 19.8 |  | 21.7 |
| 1 month | 18.28 | | 21.7 |
| Current year | 16.3 | | 24.5 |
| 1 year | 16.3 | | 33.1 |
| 3 years | 16.3 | | 51.4 |
| 5 years | 16.3 | | 147.4 |
| 10 years | 16.3 | | 147.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 59 | 01/04/2011 |
Tanja Bücherl
DFI | Director of Finance/CFO | 38 | 01/11/2025 |
Sandra Dittus
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Hiller
CHM | Chairman | 60 | 29/05/2019 |
Rolf Vornhagen
BRD | Director/Board Member | 73 | 21/07/2020 |
Georg Heni
CHM | Chairman | 68 | 20/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/03/23 | Buy | Chief Executive Officer | 150 | 0.0012% | ||
| 15/03/23 | Buy | Chief Executive Officer | 145 | 0.0012% | ||
| 13/03/23 | Buy | Chief Executive Officer | 220 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | +1.48% | -22.60% | -57.93% | 29Cr | |
| +0.89% | +7.13% | +30.84% | +11.26% | 22TCr | |
| -0.92% | +6.50% | +3.84% | -18.78% | 15TCr | |
| +2.00% | +8.95% | -14.97% | +31.77% | 14TCr | |
| +1.45% | +4.28% | -50.18% | +0.31% | 7.42TCr | |
| +1.77% | +4.53% | +19.83% | +17.94% | 5.4TCr | |
| -0.67% | +0.46% | -14.80% | -16.32% | 5.09TCr | |
| +0.52% | +7.39% | +30.98% | +17.84% | 4.22TCr | |
| +0.78% | +4.78% | +48.59% | +42.29% | 4.07TCr | |
| -0.26% | +3.54% | -0.34% | +1.62% | 3.29TCr | |
| Average | +0.32% | +4.92% | +3.12% | +3.00% | 8.06TCr | |
| Weighted average by Cap. | +0.45% | +6.23% | +6.45% | +8.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27Cr 31Cr 25Cr 23Cr 43Cr 2.94TCr 44Cr 293.23Cr 114.89Cr 1.47TCr 115.74Cr 113.22Cr 4.91TCr | 28Cr 33Cr 27Cr 24Cr 46Cr 3.12TCr 46Cr 311.61Cr 122.09Cr 1.56TCr 122.99Cr 120.31Cr 5.22TCr |
| Net income | 1.4Cr 1.62Cr 1.31Cr 1.2Cr 2.25Cr 154.33Cr 2.29Cr 15Cr 6.03Cr 77Cr 6.08Cr 5.94Cr 257.71Cr | 1.83Cr 2.11Cr 1.71Cr 1.56Cr 2.94Cr 201.25Cr 2.99Cr 20Cr 7.86Cr 100.73Cr 7.92Cr 7.75Cr 336.06Cr |
| Net Debt | 10Cr 12Cr 9.42Cr 8.59Cr 16Cr 1.11TCr 16Cr 110.42Cr 43Cr 554.16Cr 44Cr 43Cr 1.85TCr | 9.77Cr 11Cr 9.15Cr 8.35Cr 16Cr 1.08TCr 16Cr 107.24Cr 42Cr 538.21Cr 42Cr 41Cr 1.8TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | €20.55 | -0.48% | 2,382 |
| 11/26/11 | €20.65 | +1.72% | 5,201 |
| 10/26/10 | €20.30 | -0.49% | 5,935 |
| 07/26/07 | €20.40 | +2.00% | 7,030 |
| 06/26/06 | €20.00 | -1.23% | 5,096 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SBS Stock
Select your edition
All financial news and data tailored to specific country editions
